Document is current

Article History

Received: 14 September 2023

Revised: 24 October 2023

Accepted: 28 October 2023

First Online: 25 November 2023

Declarations

:

: The scientific guarantor of this publication is Àlex Rovira.

: Àlex Rovira serves/ed on scientific advisory boards for Novartis, Sanofi-Genzyme, Icometrix, SyntheticMR, Bayer Healthcare, Biogen, and OLEA Medical, and has received speaker honoraria from Bayer Healthcare, Sanofi-Genzyme, Bracco Imaging, Merck-Serono, Teva Pharmaceutical Industries Ltd., Novartis, Roche, and Biogen. He is a member of the ESMRMB-GREC Working Group whose yearly meetings have received unconditional support from Bayer Healthcare, Bracco Imaging, GE HealthCare, and Guerbet.Carlo Cosimo Quattrocchi has signed speaker contracts with Bayer Healthcare, Bracco Imaging, and Guerbet. He is co-chair of the ESMRMB-GREC Working Group whose yearly meetings have received unconditional support from Bayer Healthcare, Bracco Imaging, GE HealthCare, and Guerbet. He is a member of the ESUR-CMSC whose 2-yearly meetings have received support from Bayer Healthcare, Bracco Imaging, GE HealthCare, and Guerbet.

: No complex statistical methods were necessary for this paper.

: Written informed consent was not required.

: Institutional Review Board approval was not required.

: Not applicable.

: • commentary